Domov › Alopecia areata › Kalifornia
Klinické štúdie Alopecia areata v štáte Kalifornia
10 štúdií pre Alopecia areata hľadá účastníkov v zariadeniach v štáte Kalifornia.
Mestá v štáte Kalifornia
Oficiálny text štúdie (anglicky)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dermatology Research Associates - Los Angeles /ID# 282821, Los Angeles
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Center For Dermatology Clinical Research, Inc., Fremont
- Northridge Clinical Trials, Northridge
- Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita
Prebieha náborFáza 2
Vek 18 až 50 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Doc1 Healthcare Systems, Brea
- University of California - Irvine, Irvine
- Gavin Herbert Eye Institute, Irvine
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- California Dermatology & Clinical Research Institute, Encinitas
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT07733765Dupilumab in the Treatment of Pediatric Alopecia Areata
- University of California, Irvine, Irvine
- University of California San Diego, San Diego
Prebieha náborFáza 2
Vek 6 až 17 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05866562A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Exalt Clinical Research /ID# 283814, Chula Vista
- First Oc Dermatology /ID# 259220, Fountain Valley
- Dermatology Research Associates /ID# 258033, Los Angeles
- a 3 ďalších
Prebieha náborFáza 3
Vek 12 až 63 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06012240Regeneron AA Multicenter (Dupilumab)
- University of California, Irvine, Irvine
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 6. 2026 · NCT05551793A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- California Dermatology & Clinical Research Institute, Encinitas
Prebieha náborFáza 3
Vek 6 až 14 · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Clinical Trial Research Institute, Thousand Oaks
Prebieha náborFáza 1/2
Vek 18 až 55 · Všetky pohlavia · Aktualizované 4. 3. 2026 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Kern Research Inc., Bakersfield
- Center For Dermatology Clinical Research Inc., Fremont
- Dermatology Research Associates, Los Angeles
- a 2 ďalších
Prebieha náborFáza 3
Vek 12 až 17 · Všetky pohlavia · Aktualizované 28. 1. 2026 · NCT07133308Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.